PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 18 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $21,000 | 0.0% | 21,000 | 0.0% | 0.00% | – |
| Q3 2017 | $21,000 | 0.0% | 21,000 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | -54.3% | 21,000 | -54.3% | 0.00% | – |
| Q1 2017 | $46,000 | +48.4% | 46,000 | +48.4% | 0.00% | – |
| Q4 2016 | $31,000 | -51.6% | 31,000 | -53.0% | 0.00% | – |
| Q3 2016 | $64,000 | +137.0% | 66,000 | +127.6% | 0.00% | – |
| Q2 2016 | $27,000 | +50.0% | 29,000 | +45.0% | 0.00% | – |
| Q1 2016 | $18,000 | -21.7% | 20,000 | -33.3% | 0.00% | – |
| Q4 2015 | $23,000 | -91.6% | 30,000 | -90.3% | 0.00% | – |
| Q3 2015 | $273,000 | +396.4% | 308,000 | +431.0% | 0.00% | – |
| Q2 2015 | $55,000 | +111.5% | 58,000 | +114.8% | 0.00% | – |
| Q1 2015 | $26,000 | +36.8% | 27,000 | +35.0% | 0.00% | – |
| Q4 2014 | $19,000 | -51.3% | 20,000 | -50.0% | 0.00% | – |
| Q3 2014 | $39,000 | +69.6% | 40,000 | +100.0% | 0.00% | – |
| Q2 2014 | $23,000 | -34.3% | 20,000 | -39.4% | 0.00% | – |
| Q1 2014 | $35,000 | – | 33,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|